Diabetologia

Up front February 2016

Novel approaches to treating type 2 diabetes

Michael A. Nauck

G protein-coupled receptors as new therapeutic targets for type 2 diabetes

Frank Reimann, Fiona M. Gribble

Night-time blood pressure: a role in the prediction and prevention of diabetes?

Martin K. Rutter

Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies

Eileen Morgan, Sophia R. Halliday, Gemma R. Campbell, Chris R. Cardwell, Chris C. Patterson

Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention

Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

Michael A. Nauck, Murray W. Stewart, Christopher Perkins, Angela Jones-Leone, Fred Yang, Caroline Perry, Rickey R. Reinhardt, Marc Rendell

The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study

Marlene Ø. Krag, Lotte Hasselbalch, Volkert Siersma, Anni B. S. Nielsen, Susanne Reventlow, Kirsti Malterud, Niels de Fine Olivarius

Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus

Florian C. Bonke, Ewan Donnachie, Antonius Schneider, Michael Mehring

Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients

Mara Catani, Denise Walther, Michael R. Christie, Kerry A. McLaughlin, Ezio Bonifacio, Anne Eugster

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)

Shona J. Livingstone, Helen C. Looker, Tahira Akbar, D. John Betteridge, Paul N. Durrington, Graham A. Hitman, H. Andrew W. Neil, John H. Fuller, Helen M. Colhoun

Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis

Min Xu, Xiaofei Lv, Lan Xie, Xiaolin Huang, Ya Huang, Ying Chen, Kui Peng, Po Wang, Weiqing Wang, Lu Qi, Yufang Bi, Yimin Sun, Guang Ning

Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models

Fang Chen, Min Sha, Yanyang Wang, Tijun Wu, Wei Shan, Jia Liu, Wenbo Zhou, Yunxia Zhu, Yujie Sun, Yuguang Shi, David Bleich, Xiao Han

Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients

Enrica Favaro, Andrea Carpanetto, Cristiana Caorsi, Mirella Giovarelli, Costanza Angelini, Paolo Cavallo-Perin, Ciro Tetta, Giovanni Camussi, Maria M. Zanone

Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes

Carolyn C. Richardson, Kerry A. McLaughlin, Diana Morgan, Richard G. Feltbower, Michael R. Christie

Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans

Manoj Amrutkar, Matthias Kern, Esther Nuñez-Durán, Marcus Ståhlman, Emmelie Cansby, Urszula Chursa, Elin Stenfeldt, Jan Borén, Matthias Blüher, Margit Mahlapuu

RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice

Xiang Ma, Zan Zhou, Yaqiong Chen, Yuting Wu, Yi Liu

Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes

Vivi R. Steenberg, Signe M. Jensen, Jens Pedersen, Andreas N. Madsen, Johanne A. Windeløv, Birgitte Holst, Bjørn Quistorff, Steen S. Poulsen, Jens J. Holst

Cardiac 82Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes

Bernt J. von Scholten, Philip Hasbak, Thomas E. Christensen, Adam A. Ghotbi, Andreas Kjaer, Peter Rossing, Tine W. Hansen

Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy

Jay C. Jha, Vicki Thallas-Bonke, Claudine Banal, Stephen P. Gray, Bryna S. M. Chow, Georg Ramm, Susan E. Quaggin, Mark E. Cooper, Harald H. H. W. Schmidt, Karin A. Jandeleit-Dahm

Antihypertensive medication prior to nocturnal sleep reduces the risk of new-onset type 2 diabetes in hypertensive patients: a role for slow-wave sleep?

Christian Benedict

Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention

Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

Ramón C. Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Erratum to: Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals

Ghadi Antoun, Fiona McMurray, A. Brianne Thrush, David A. Patten, Alyssa C. Peixoto, Ruth S. Slack, Ruth McPherson, Robert Dent, Mary-Ellen Harper